Advances in organ repair, tissue repair and tissue engineering have revolutionized the way experimental orthopedics is looked at. The ability to manufacture cocktails of stem cells, biologics and small molecules joined through biocompatible scaffolds is now being regularly used to restore both structure and function of damaged ligaments, tendons, teeth, bone, cartilage, facet joints and intervertebral discs. The relevance of developing bone and orthopedics compounds stems from their usability in both trauma (patients recovering from MVAs, etc.) and medical (spinal osteoarthritis, osteoporosis, etc.) patients.

Creating novel bone and orthopedics models needs no justification in a world where new pathologies are constantly appearing and even evolving. This is where PharmaLegacy comes in: Our plethora of in vivo and ex vivo models are crafted by some of the most skilled experts in pharmacology. With our wide collections of models with immediate availability, you could be collecting data in just two weeks. Have any doubts or questions? You won’t after you speak with our scientists. Get in touch now.

Contact Us


Can you trust your animal model to provide you with the correct answers?

No animal study can predict with complete certainty how a therapy will perform in human subjects, but
it is PharmaLegacy’s job to ensure that you come as close to certainty as possible. Download our
brochure on non-human primate (NHP) models and see how PharmaLegacy ensures that your studies utilize
the most physiologically relevant models.


    Enforcing quality:

    • Capacity to house over 30,000 rodents and large animals
    • Electronically managed, traceable research data
    • 380,000 square feet of facility space
    • Research data electronically managed by BioBook (IDBS, UK)
    quality section

    Work with the CRO that has the most experience in pharmacology. Work with PharmaLegacy.